More men with advanced prostate cancer could be successfully treated with precision drug olaparib 15 Jul 2024 Scientists have discovered a genetic aberration found in some prostate cancers that could allow more men to be successfully treated with targeted drug olaparib Find out more Show/Hide
New tool combining evolution and AI predicts prostate cancer recurrence more than a decade ahead 11 Jul 2024 Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed computational methods to capture specific tumour measurements relating to the tumour’s ability to change over time. They then showed that these measurements correlate with disease recurrence more than a decade after the initial diagnosis. Find out more Show/Hide
Analysis of findings from long-term study reveals more genetic mutations associated with aggressive prostate cancer 02 Jul 2024 Scientists have added to the list of inherited genetic mutations known to increase the risk of more aggressive prostate cancer. Find out more Show/Hide
ASCO 2024: Prostate cancer spit test better for men with high genetic risk than standard blood test 31 May 2024
New trial finds radiotherapy combined with hormone therapy can help some advanced prostate cancer patients avoid chemotherapy 08 May 2024
Scientists now able to predict response to radium-223 treatment in prostate cancer bone metastases 21 Dec 2023
Research uncovers genetic clues to high rates of prostate cancer in men with African ancestry – improving risk prediction 09 Nov 2023
Scientists reverse drug resistance in prostate cancer by targeting 'hijacked' white blood cells 16 Oct 2023